JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265514

Human DPM2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

DPM2 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 2 and 4 bp deletion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

View Alternative Names

Dolichol phosphate (beta D) mannosyltransferase 2, Dolichol phosphate mannose biosynthesis regulatory protein, Dolichol phosphate mannose synthase 2, Dolichyl phosphate mannosyltransferase 2, Dolichyl phosphate mannosyltransferase polypeptide 2, regulatory subunit, R75484, RP23 255P20.5

2 Images
Sanger Sequencing - Human DPM2 knockout HeLa cell line (AB265514)
  • Sanger seq

Unknown

Sanger Sequencing - Human DPM2 knockout HeLa cell line (AB265514)

Allele-1 : 4 bp deletion in exon 2.

Sanger Sequencing - Human DPM2 knockout HeLa cell line (AB265514)
  • Sanger seq

Unknown

Sanger Sequencing - Human DPM2 knockout HeLa cell line (AB265514)

Allele-2 : 2 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 2 and 4 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265514-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265514-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265514 Human DPM2 knockout HeLa cell line", "number":"AB265514-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265514-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265514-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265514 Human DPM2 knockout HeLa cell line", "number":"AB265514-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265514-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265514 Human DPM2 knockout HeLa cell line", "number":"AB265514-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265514-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265514 Human DPM2 knockout HeLa cell line", "number":"AB265514-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
DPM2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DPM2 also known as dolichyl-phosphate mannosyltransferase polypeptide 2 is a component of the dolichol-phosphate mannose (DPM) synthase complex. This protein weighs approximately 25 kDa and plays a significant role in mannose transfer. It is ubiquitously expressed in various tissues with higher expression levels in the liver heart and muscle. The DPM2 works as a regulator and stabilizer within the DPM synthase complex essential for glycosylation processes.
Biological function summary

DPM2 is involved in the assembly of the glycosylation precursor dolichol-phosphate-mannose which is critical for the proper synthesis of glycoproteins. As part of the DPM synthase complex DPM2 teams with the catalytic subunit DPM1 and the anchoring subunit DPM3. These interactions ensure effective glycosylation necessary for protein folding and function. The glycosylation process is essential for the stability and activity of numerous proteins within eukaryotic organisms.

Pathways

DPM2 plays a central role in the protein glycosylation pathway and the synthesis of glycosylphosphatidylinositol (GPI) anchors. It works closely with DPM1 activating it to transfer mannose molecules from GDP-mannose to dolichol-phosphate an important step in the formation of GPI-anchored proteins. These pathways are vital for cell surface expression and protein localization implicating DPM2 in broader cell signaling and communication networks.

DPM2 mutations are linked to Congenital Disorders of Glycosylation (CDG) particularly CDG-Iu. These conditions affect multiple systems due to improper glycosylation leading to symptoms ranging from developmental delays to organ dysfunction. Furthermore DPM2 in association with DPM1 and other partners in the DPM synthase complex has connections to muscular dystrophies due to its role in muscle glycosylation processes. Understanding these relationships is important for developing therapeutic interventions targeting glycosylation-related disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com